Importance of the Extracellular Loop 4 in the Human Serotonin Transporter for Inhibitor Binding and Substrate Translocation. 2015

Hafsteinn Rannversson, and Pamela Wilson, and Kristina Birch Kristensen, and Steffen Sinning, and Anders Skov Kristensen, and Kristian Strømgaard, and Jacob Andersen
From the Department of Drug Design and Pharmacology, University of Copenhagen, DK-2100 Copenhagen and.

The serotonin transporter (SERT) terminates serotonergic neurotransmission by performing reuptake of released serotonin, and SERT is the primary target for antidepressants. SERT mediates the reuptake of serotonin through an alternating access mechanism, implying that a central substrate site is connected to both sides of the membrane by permeation pathways, of which only one is accessible at a time. The coordinated conformational changes in SERT associated with substrate translocation are not fully understood. Here, we have identified a Leu to Glu mutation at position 406 (L406E) in the extracellular loop 4 (EL4) of human SERT, which induced a remarkable gain-of-potency (up to >40-fold) for a range of SERT inhibitors. The effects were highly specific for L406E relative to six other mutations in the same position, including the closely related L406D mutation, showing that the effects induced by L406E are not simply charge-related effects. Leu(406) is located >10 Å from the central inhibitor binding site indicating that the mutation affects inhibitor binding in an indirect manner. We found that L406E decreased accessibility to a residue in the cytoplasmic pathway. The shift in equilibrium to favor a more outward-facing conformation of SERT can explain the reduced turnover rate and increased association rate of inhibitor binding we found for L406E. Together, our findings show that EL4 allosterically can modulate inhibitor binding within the central binding site, and substantiates that EL4 has an important role in controlling the conformational equilibrium of human SERT.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D017354 Point Mutation A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair. Mutation, Point,Mutations, Point,Point Mutations

Related Publications

Hafsteinn Rannversson, and Pamela Wilson, and Kristina Birch Kristensen, and Steffen Sinning, and Anders Skov Kristensen, and Kristian Strømgaard, and Jacob Andersen
February 1991, Biochemical Society transactions,
Hafsteinn Rannversson, and Pamela Wilson, and Kristina Birch Kristensen, and Steffen Sinning, and Anders Skov Kristensen, and Kristian Strømgaard, and Jacob Andersen
February 2008, Molecular membrane biology,
Hafsteinn Rannversson, and Pamela Wilson, and Kristina Birch Kristensen, and Steffen Sinning, and Anders Skov Kristensen, and Kristian Strømgaard, and Jacob Andersen
February 1997, Biochemistry,
Hafsteinn Rannversson, and Pamela Wilson, and Kristina Birch Kristensen, and Steffen Sinning, and Anders Skov Kristensen, and Kristian Strømgaard, and Jacob Andersen
January 2014, Naunyn-Schmiedeberg's archives of pharmacology,
Hafsteinn Rannversson, and Pamela Wilson, and Kristina Birch Kristensen, and Steffen Sinning, and Anders Skov Kristensen, and Kristian Strømgaard, and Jacob Andersen
March 2012, Journal of molecular modeling,
Hafsteinn Rannversson, and Pamela Wilson, and Kristina Birch Kristensen, and Steffen Sinning, and Anders Skov Kristensen, and Kristian Strømgaard, and Jacob Andersen
August 2025, Structure (London, England : 1993),
Hafsteinn Rannversson, and Pamela Wilson, and Kristina Birch Kristensen, and Steffen Sinning, and Anders Skov Kristensen, and Kristian Strømgaard, and Jacob Andersen
April 2019, Nature communications,
Hafsteinn Rannversson, and Pamela Wilson, and Kristina Birch Kristensen, and Steffen Sinning, and Anders Skov Kristensen, and Kristian Strømgaard, and Jacob Andersen
December 2019, Neuropharmacology,
Hafsteinn Rannversson, and Pamela Wilson, and Kristina Birch Kristensen, and Steffen Sinning, and Anders Skov Kristensen, and Kristian Strømgaard, and Jacob Andersen
March 2012, The Journal of biological chemistry,
Hafsteinn Rannversson, and Pamela Wilson, and Kristina Birch Kristensen, and Steffen Sinning, and Anders Skov Kristensen, and Kristian Strømgaard, and Jacob Andersen
June 2004, The Journal of biological chemistry,
Copied contents to your clipboard!